1. Stocks
  2. Norris Medicines Ltd.
  3. Swot
swot-logo

Norris Medicines Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Norris Medicines Ltd. has 19 Strengths, 5 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

MACD Crossover Above Signal Line

Price crossing above SMA20 today, and greater than SMA5

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Stocks in uptrend most likely to cross above SMA-200 soon

MACD crossed above signal line previous end of day

Biggest Price Gainers from Open

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Increasing Trend in Non-Core Income

Bullish or Bearish Candlestick Strength - Indices

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)